Use este identificador para citar o ir al link de este elemento: http://hdl.handle.net/1843/56329
Registro completo de metadatos
Campo DCValorIdioma
dc.creatorSalvina Maria Decampos-carlipt_BR
dc.creatorJoão Vinícius Salgadopt_BR
dc.creatorAntonio Lucio Teixeira Juniorpt_BR
dc.creatorÉrica Leandro Marciano Vieirapt_BR
dc.creatorNatalia Pessoa Rochapt_BR
dc.creatorKeliane de Oliveirapt_BR
dc.creatorFernanda Carneiro Guimarãespt_BR
dc.creatorIzabela Guimarães Barbosapt_BR
dc.creatorJoão Luís Vieira Monteiro de Barrospt_BR
dc.creatorOlaoluwa Okusagapt_BR
dc.creatorOlindo Assis Martins-filhopt_BR
dc.date.accessioned2023-07-14T22:40:19Z-
dc.date.available2023-07-14T22:40:19Z-
dc.date.issued2017-10-14-
dc.citation.volume44pt_BR
dc.citation.issue6pt_BR
dc.citation.spage145pt_BR
dc.citation.epage148pt_BR
dc.identifier.doihttps://doi.org/10.1590/0101-60830000000140pt_BR
dc.identifier.issn1806938Xpt_BR
dc.identifier.urihttp://hdl.handle.net/1843/56329-
dc.description.resumoBackground: Toxoplasma gondii (T. gondii) infection has been identified as a risk factor for schizophrenia. Objectives: Herein, we sought to evaluate the association between T. gondii infection and clinical symptoms and quality of life in patients with schizophrenia. Methods: We conducted a cross-sectional study with 48 patients with chronic schizophrenia and 40 controls. Peripheral blood was drawn, and IgM and IgG anti-T. gondii antibodies were evaluated by Enzyme-Linked Immunosorbent Assay (ELISA). Depressive, positive and negative symptoms were assessed, respectively, by the Calgary Depression Scale (CDS) and the Positive and Negative Syndrome Scale (PANSS). Cognitive performance was assessed in patients by the Brazilian version of the Schizophrenia Cognition Rating Scale (SCoRS-BR). Quality of life was assessed by the Brazilian version of the Quality of Life in Schizophrenia scale (QLS-BR). Results: The prevalence and titers of T. gondii IgM and IgG antibodies did not differ between patients and controls. The positive serology for T. gondii IgG antibodies was not associated with illness symptoms, cognitive performance, depressive symptoms or quality of life. Discussion: Our findings suggest that toxoplasmosis infection is not associated with severity of symptoms, quality of life, cognitive or depressive symptoms in schizophrenia patients.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentICB - DEPARTAMENTO DE FARMACOLOGIApt_BR
dc.publisher.departmentICB - DEPARTAMENTO DE MORFOLOGIApt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofArchives of Clinical Psychiatry (São Paulo)-
dc.rightsAcesso Abertopt_BR
dc.subjectToxoplasma gondiipt_BR
dc.subjectSchizophreniapt_BR
dc.subjectCognitionpt_BR
dc.subjectDepressionpt_BR
dc.subjectQuality of lifept_BR
dc.subject.otherToxoplasmapt_BR
dc.subject.otherEsquizofreniapt_BR
dc.subject.otherTranstornos Cognitivospt_BR
dc.subject.otherDepressãopt_BR
dc.subject.otherQualidade de vidapt_BR
dc.titleToxoplasma gondii infection and chronic schizophrenia: is there any association?pt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.scielo.br/j/rpc/a/tLzT6y34hmXn6dwngNXK4tQ/pt_BR
Aparece en las colecciones:Artigo de Periódico

archivos asociados a este elemento:
archivo Descripción TamañoFormato 
Toxoplasma gondii infection and chronic schizophrenia pdfa.pdf118.08 kBAdobe PDFVisualizar/Abrir


Los elementos en el repositorio están protegidos por copyright, con todos los derechos reservados, salvo cuando es indicado lo contrario.